0000920465-15-000066.txt : 20150902
0000920465-15-000066.hdr.sgml : 20150902
20150902210152
ACCESSION NUMBER: 0000920465-15-000066
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150831
FILED AS OF DATE: 20150902
DATE AS OF CHANGE: 20150902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10182 TELESIS COURT, 6TH FLOOR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 10182 TELESIS COURT, 6TH FLOOR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chawla Lakhmir S
CENTRAL INDEX KEY: 0001646626
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 151090590
MAIL ADDRESS:
STREET 1: 1960 KIRBY ROAD
CITY: MCLEAN
STATE: VA
ZIP: 22101
4
1
wf-form4_144124210144431.xml
FORM 4
X0306
4
2015-08-31
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001646626
Chawla Lakhmir S
C/O LA JOLLA PHARMACEUTICAL COMPANY,
10182 TELESIS COURT, 6TH FLOOR
SAN DIEGO
CA
92121
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
35.58
2015-08-31
4
A
0
60000
0
A
2025-08-31
Common Stock
60000.0
60000
D
Stock Option (Right to Buy)
35.58
2015-08-31
4
A
0
40000
0
A
2025-08-31
Common Stock
40000.0
40000
D
This option represents a right to purchase a total of 60,000 shares of the Issuer's Common Stock, which shall vest in 48 equal monthly installments starting on 9/30/2015.
Option vests and becomes exercisable upon the achievement of certain performance-related goals in 2016. The timing for the achievement of such goals determines the number of shares underlying the award.
Represents the maximum number of shares of common stock underlying the option grant, with the actual number of shares issuable upon exercise to be determined based on the timing of the achievement of the vesting criteria described in footnote 2.
/s/ Chester S. Zygmont, III as attorney-in-fact for Lakhmir S. Chawla
2015-09-02